Carlson Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-151,320
Closed -$21.1M 260
2019
Q2
$21.1M Buy
151,320
+27,146
+22% +$3.76M 0.32% 96
2019
Q1
$17.4M Buy
124,174
+119,624
+2,629% +$16M 0.31% 107
2018
Q4
$587K Sell
4,550
-20,876
-82% -$2.91M 0.01% 260
2018
Q3
$3.51M Buy
+25,426
New +$3.38M 0.04% 242
2018
Q2
Sell
-142,820
Closed -$18.3M 279
2018
Q1
$18.3M Buy
+142,820
New +$19.3M 0.28% 94
2015
Q1
Sell
-11,700
Closed -$1.22M 346
2014
Q4
$1.22M Buy
+11,700
New +$1.23M 0.01% 296
2014
Q3
Sell
-161,980
Closed -$16.9M 355
2014
Q2
$16.9M Sell
161,980
-224,960
-58% -$22.7M 0.19% 167
2014
Q1
$38M Buy
386,940
+10,825
+3% +$1M 0.44% 76
2013
Q4
$34.4M Buy
376,115
+231,605
+160% +$21.3M 0.39% 87
2013
Q3
$12.5M Sell
144,510
-83,810
-37% -$7.52M 0.17% 199
2013
Q2
$19.6M Buy
+228,320
New +$19.4M 0.24% 138

Other funds holding JNJ

Carlson Capital's JNJ Position: Q3 2019 in Review

Carlson Capital sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 151,320 shares — an estimated $21.1M sold.

Carlson Capital first reported a position in JNJ in Q2 2013 and held it in 11 quarters. The position peaked at $38M in Q1 2014. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Carlson Capital reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
  • Carlson Capital sold 151,320 Johnson & Johnson shares in Q3 2019, an estimated $21.1M.
  • Carlson Capital first reported a position in Johnson & Johnson in Q2 2013 and held it in 11 quarters.
  • Carlson Capital's Johnson & Johnson position peaked at $38M in Q1 2014.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Carlson Capital's 13F filing for Q3 2019, filed 13 Nov 2019.